2015Journal of Clinical Pulmonary MedicineRequires access

Protective effect of dexmedetomidine on lung injury after cardiac surgery under cardiopulmonary bypass

Chen Zhuan-qia

Open publisher page 1 citations

Abstract

Objective To research the protective effect of dexmedetomidine on lung injury after cardiac surgery under cardiopulmonary bypass. Methods 60 cases of cardiac surgery patients in our hospital were selected and randomly divided into two groups,each 30 cases. The observation group was given 0. 7 μg /( kgoh) dexmedetomidine after anesthesia at the end of surgery,and the control group was not given any treatment. The levels of TNF-α,IL-1β and IL-6 and alveolar-arterial oxygen difference( Aa DO2),oxygenation index( OI),respiratory index( RI) of the two groups were detected at T0( before administration),T1( before CPB),T2( after the shutdown 1h),T3( after stopping 4h),and T4( after stopping 24h). Results The levels of TNF-α,IL-1β and IL-6 of the two groups at T1~ T4 point showed a decreasing trend after the first increases,and the difference was statistically significant at each point( P 0. 05). The levels of TNF-α,IL-1β and IL-6 were significantly lower in the observation group than in the control group( P 0. 05). The value of Aa DO2 and RI of the two groups at T1~ T3 showed a increasing trend( P 0. 05),and the value of OI of the two groups at T1~ T3 showed a decreasing trend. The values of Aa DO2,OI and RI were significantly lower in the observation group than in the control group( P 0. 05). Conclusion Dexmedetomidine can effectively inhibit inflammation and repair lung injury of heart surgery patients with cardiopulmonary bypass.

About this research paper

What this paper is about

Objective To research the protective effect of dexmedetomidine on lung injury after cardiac surgery under cardiopulmonary bypass. Methods 60 cases of cardiac surgery patients in our hospital were selected and randomly divided into two groups,each 30 cases. The observation group was given 0. 7 μg /( kgoh) dexmedetomidine after anesthesia at the end of surgery,and the control group was not given any treatment. The levels of TNF-α,IL-1β and IL-6 and alveolar-arterial oxygen difference( Aa DO2),oxygenation index( OI),respiratory index( RI) of the two groups were detected at T0( before administration),T1( before CPB),T2( after the shutdown 1h),T3( after stopping 4h),and T4( after stopping 24h). Results The levels of TNF-α,IL-1β and IL-6 of the two groups at T1~ T4 point showed a decreasing trend after the first increases,and the difference was statistically significant at each point( P 0. 05). The levels of TNF-α,IL-1β and IL-6 were significantly lower in the observation group than in the control group( P 0. 05). The value of Aa DO2 and RI of the two groups at T1~ T3 showed a increasing trend( P 0. 05),and the value of OI of the two groups at T1~ T3 showed a decreasing trend. The values of Aa DO2,OI and RI were significantly lower in the observation group than in the control group( P 0. 05). Conclusion Dexmedetomidine can effectively inhibit inflammation and repair lung injury of heart surgery patients with cardiopulmonary bypass.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To research the protective effect of dexmedetomidine on lung injury after cardiac surgery under cardiopulmonary bypass. Methods 60 cases of cardiac surgery patients in our hospital were selected and randomly divided into two groups,each 30 cases. The observation group was given 0. 7 μg /( kgoh) dexmedetomidine after anesthesia at the end of surgery,and the control group was not given any treatment. The levels of TNF-α,IL-1β and IL-6 and alveolar-arterial oxygen difference( Aa DO2),oxygenation index( OI),respiratory index( RI) of the two groups were detected at T0( before administration),T1( before CPB),T2( after the shutdown 1h),T3( after stopping 4h),and T4( after stopping 24h). Results The levels of TNF-α,IL-1β and IL-6 of the two groups at T1~ T4 point showed a decreasing trend after the first increases,and the difference was statistically significant at each point( P 0. 05). The levels of TNF-α,IL-1β and IL-6 were significantly lower in the observation group than in the control group( P 0. 05). The value of Aa DO2 and RI of the two groups at T1~ T3 showed a increasing trend( P 0. 05),and the value of OI of the two groups at T1~ T3 showed a decreasing trend. The values of Aa DO2,OI and RI were significantly lower in the observation group than in the control group( P 0. 05). Conclusion Dexmedetomidine can effectively inhibit inflammation and repair lung injury of heart surgery patients with cardiopulmonary bypass.

Key concepts: Dexmedetomidine, Medicine, Cardiopulmonary bypass, Anesthesia, Oxygenation index, Cardiac surgery, Cardiac index, Lung

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective effect of dexmedetomidine on lung injury after cardiac surgery under cardiopulmonary bypass — Research Paper | ScholarLens